Ryan Specialty (NYSE:RYAN – Get Free Report) is anticipated to post its Q3 2025 results after the market closes on Thursday, October 30th. Analysts expect Ryan Specialty to post earnings of $0.47 per share and revenue of $742.3520 million for the quarter. Individuals may review the information on the company’s upcoming Q3 2025 earningreport for the latest details on the call scheduled for Thursday, October 30, 2025 at 4:45 PM ET.
Ryan Specialty (NYSE:RYAN – Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The company reported $0.66 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.66. The business had revenue of $855.17 million for the quarter, compared to analysts’ expectations of $837.52 million. Ryan Specialty had a return on equity of 48.70% and a net margin of 6.81%.The company’s revenue was up 23.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.58 EPS. On average, analysts expect Ryan Specialty to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.
Ryan Specialty Stock Performance
RYAN opened at $53.53 on Tuesday. The stock has a market cap of $14.11 billion, a P/E ratio of 152.94, a P/E/G ratio of 1.46 and a beta of 0.63. The company has a debt-to-equity ratio of 2.88, a current ratio of 1.01 and a quick ratio of 1.01. The stock’s 50 day simple moving average is $55.09 and its 200 day simple moving average is $62.53. Ryan Specialty has a 1-year low of $50.08 and a 1-year high of $77.16.
Ryan Specialty Announces Dividend
Insider Activity
In other Ryan Specialty news, Chairman Patrick G. Ryan acquired 276,634 shares of the firm’s stock in a transaction dated Friday, September 12th. The shares were acquired at an average price of $51.84 per share, for a total transaction of $14,340,706.56. Following the completion of the acquisition, the chairman directly owned 13,699,959 shares of the company’s stock, valued at $710,205,874.56. This trade represents a 2.06% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. 52.21% of the stock is owned by company insiders.
Institutional Investors Weigh In On Ryan Specialty
Several hedge funds have recently made changes to their positions in RYAN. Viking Global Investors LP boosted its holdings in shares of Ryan Specialty by 47.8% during the second quarter. Viking Global Investors LP now owns 1,412,767 shares of the company’s stock worth $96,054,000 after purchasing an additional 456,878 shares during the last quarter. Bank of America Corp DE boosted its holdings in Ryan Specialty by 47.1% in the second quarter. Bank of America Corp DE now owns 1,171,141 shares of the company’s stock valued at $79,626,000 after acquiring an additional 375,191 shares during the last quarter. Sei Investments Co. boosted its holdings in Ryan Specialty by 45.5% in the second quarter. Sei Investments Co. now owns 596,125 shares of the company’s stock valued at $40,531,000 after acquiring an additional 186,479 shares during the last quarter. Goldman Sachs Group Inc. boosted its holdings in Ryan Specialty by 46.3% in the first quarter. Goldman Sachs Group Inc. now owns 376,154 shares of the company’s stock valued at $27,787,000 after acquiring an additional 119,055 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Ryan Specialty by 11.3% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 332,823 shares of the company’s stock valued at $24,586,000 after acquiring an additional 33,667 shares during the last quarter. Institutional investors and hedge funds own 84.82% of the company’s stock.
Analyst Ratings Changes
A number of equities research analysts recently weighed in on the company. Wells Fargo & Company upped their price target on Ryan Specialty from $60.00 to $64.00 and gave the stock an “overweight” rating in a report on Wednesday, October 8th. Citigroup initiated coverage on Ryan Specialty in a report on Wednesday, August 13th. They set a “buy” rating and a $74.00 target price on the stock. Morgan Stanley lowered their target price on Ryan Specialty from $68.00 to $65.00 and set an “overweight” rating on the stock in a report on Tuesday, October 7th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Ryan Specialty in a report on Wednesday, October 8th. Finally, UBS Group lowered their target price on Ryan Specialty from $80.00 to $75.00 and set a “buy” rating on the stock in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $71.08.
View Our Latest Stock Analysis on RYAN
Ryan Specialty Company Profile
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
See Also
- Five stocks we like better than Ryan Specialty
- Investing in Travel Stocks Benefits
- Growth Picks: 3 Low-Cost Stocks That Could Double in Value
- 3 Best Fintech Stocks for a Portfolio Boost
- Are These 3 Beaten-Down Stocks Ready to Rebound?
- What is the Shanghai Stock Exchange Composite Index?
- Does the Trump-Induced Quantum Stock Rally Have Legs?
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.
